Oxford Asset Management’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History

Oxford Asset Management’s Portfolio GRTS Stock Details GRTS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-100,607	Closed	-$902K	–	1399
2019 Q4	$902K	Sell	100,607 -24,559	-20%	-$205K	0.03%	926
2019 Q3	$1.08M	Buy	125,166 +79,330	+173%	+$801K	0.03%	900
2019 Q2	$511K	Buy	+45,836	New	+$524K	0.01%	1270

Other funds holding GRTS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VVM

Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return

Peter Svennilson $1.23B AUM 301.34% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return

Oxford Asset Management's GRTS Position: Q1 2020 in Review

Oxford Asset Management sold out of Gritstone bio, Inc. Common Stock (GRTS) in Q1 2020, closing a stake of 100,607 shares — an estimated $902K sold.

Oxford Asset Management first reported a position in GRTS in Q2 2019 and held it in 3 quarters. The position peaked at $1.08M in Q3 2019. 66 funds tracked by Wall St. Rank hold GRTS as of Q1 2020.

Oxford Asset Management reported no remaining Gritstone bio, Inc. Common Stock position as of Q1 2020 after selling out during the quarter.
Oxford Asset Management sold 100,607 Gritstone bio, Inc. Common Stock shares in Q1 2020, an estimated $902K.
Oxford Asset Management first reported a position in Gritstone bio, Inc. Common Stock in Q2 2019 and held it in 3 quarters.
Oxford Asset Management's Gritstone bio, Inc. Common Stock position peaked at $1.08M in Q3 2019.
66 funds tracked by Wall St. Rank held Gritstone bio, Inc. Common Stock as of Q1 2020.

Based on Oxford Asset Management's 13F filing for Q1 2020, filed 15 May 2020.